Naureen Starling


Ontology type: schema:Person     


Person Info

NAME

Naureen

SURNAME

Starling

Publications in SciGraph latest 50 shown

  • 2022-04-27 Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer in QUALITY OF LIFE RESEARCH
  • 2021-11-18 Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage in NATURE COMMUNICATIONS
  • 2021-10-27 Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study in NATURE CANCER
  • 2021-10-27 Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study in NATURE CANCER
  • 2021-05-26 Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 in NATURE MEDICINE
  • 2021-05-20 Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer in NATURE ECOLOGY & EVOLUTION
  • 2020-08-03 Targeting the immune milieu in gastrointestinal cancers in JOURNAL OF GASTROENTEROLOGY
  • 2020-07-16 The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2020-07-14 Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding risk in EUROPEAN RADIOLOGY
  • 2019-11-18 Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-05-30 Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer in ONCOGENE
  • 2019-04-15 CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-10-23 Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer in ONCOGENE
  • 2017-05-19 A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C in INVESTIGATIONAL NEW DRUGS
  • 2016-02-17 Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study in BMC CANCER
  • 2016-01-09 Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey in TRIALS
  • 2015-11-05 Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001–2010 in GASTRIC CANCER
  • 2015-01-21 Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience in BMC CANCER
  • 2014-01-21 Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit in GASTRIC CANCER
  • 2011-04-26 Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience in BRITISH JOURNAL OF CANCER
  • 2009-05-12 A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma in BRITISH JOURNAL OF CANCER
  • 2008-09-23 Survival from cancer of the pancreas in England and Wales up to 2001 in BRITISH JOURNAL OF CANCER
  • 2008-09-02 Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer in BRITISH JOURNAL OF CANCER
  • 2008-07-08 Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison in BMC CANCER
  • 2008-06-24 Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses in BRITISH JOURNAL OF CANCER
  • 2007-12 Pharmacotherapy for Oesophagogastric Cancer in DRUGS
  • 2007-04-03 Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy in BRITISH JOURNAL OF CANCER
  • 2007-01-23 Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment in BRITISH JOURNAL OF CANCER
  • 2007-01 Does shorter duration of chemotherapy worsen survival for elderly patients with colon cancer? in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2005-06 Second-line therapy for advanced colorectal carcinoma in CURRENT ONCOLOGY REPORTS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.5072.0", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417581.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39009.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.451052.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413628.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.18886.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5379.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239578.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.123047.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.430506.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.443984.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415720.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10025.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415099.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416304.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.156122.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.464688.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17236.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416224.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417068.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416220.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }
        ], 
        "familyName": "Starling", 
        "givenName": "Naureen", 
        "id": "sg:person.01136565472.17", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-1496-6792"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17", 
          "https://orcid.org/0000-0002-1496-6792"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-08-04T17:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/person/person_532.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01136565472.17'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01136565472.17'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01136565472.17'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01136565472.17'


     

    This table displays all metadata directly associated to this object as RDF triples.

    63 TRIPLES      11 PREDICATES      34 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01136565472.17 schema:affiliation N6bf60de30b734157a51eeb341d382311
    2 grid-institutes:grid.10025.36
    3 grid-institutes:grid.123047.3
    4 grid-institutes:grid.156122.3
    5 grid-institutes:grid.17236.31
    6 grid-institutes:grid.18886.3f
    7 grid-institutes:grid.239578.2
    8 grid-institutes:grid.39009.33
    9 grid-institutes:grid.413628.a
    10 grid-institutes:grid.415099.0
    11 grid-institutes:grid.415720.5
    12 grid-institutes:grid.416220.3
    13 grid-institutes:grid.416224.7
    14 grid-institutes:grid.416304.4
    15 grid-institutes:grid.417068.c
    16 grid-institutes:grid.417581.e
    17 grid-institutes:grid.424926.f
    18 grid-institutes:grid.430506.4
    19 grid-institutes:grid.443984.6
    20 grid-institutes:grid.451052.7
    21 grid-institutes:grid.464688.0
    22 grid-institutes:grid.5379.8
    23 schema:familyName Starling
    24 schema:givenName Naureen
    25 schema:identifier Nf666b22d8298471eac61d9dc87306663
    26 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17
    27 https://orcid.org/0000-0002-1496-6792
    28 schema:sdDatePublished 2022-08-04T17:37
    29 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    30 schema:sdPublisher Na9e719082ccc44e183769dc4115b2812
    31 sgo:license sg:explorer/license/
    32 sgo:sdDataset persons
    33 rdf:type schema:Person
    34 N6bf60de30b734157a51eeb341d382311 schema:affiliation grid-institutes:grid.5072.0
    35 sgo:isCurrent true
    36 rdf:type schema:OrganizationRole
    37 Na9e719082ccc44e183769dc4115b2812 schema:name Springer Nature - SN SciGraph project
    38 rdf:type schema:Organization
    39 Nf666b22d8298471eac61d9dc87306663 schema:name orcid_id
    40 schema:value 0000-0002-1496-6792
    41 rdf:type schema:PropertyValue
    42 grid-institutes:grid.10025.36 schema:Organization
    43 grid-institutes:grid.123047.3 schema:Organization
    44 grid-institutes:grid.156122.3 schema:Organization
    45 grid-institutes:grid.17236.31 schema:Organization
    46 grid-institutes:grid.18886.3f schema:Organization
    47 grid-institutes:grid.239578.2 schema:Organization
    48 grid-institutes:grid.39009.33 schema:Organization
    49 grid-institutes:grid.413628.a schema:Organization
    50 grid-institutes:grid.415099.0 schema:Organization
    51 grid-institutes:grid.415720.5 schema:Organization
    52 grid-institutes:grid.416220.3 schema:Organization
    53 grid-institutes:grid.416224.7 schema:Organization
    54 grid-institutes:grid.416304.4 schema:Organization
    55 grid-institutes:grid.417068.c schema:Organization
    56 grid-institutes:grid.417581.e schema:Organization
    57 grid-institutes:grid.424926.f schema:Organization
    58 grid-institutes:grid.430506.4 schema:Organization
    59 grid-institutes:grid.443984.6 schema:Organization
    60 grid-institutes:grid.451052.7 schema:Organization
    61 grid-institutes:grid.464688.0 schema:Organization
    62 grid-institutes:grid.5072.0 schema:Organization
    63 grid-institutes:grid.5379.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...